Find News

Filter articles

Applied Filters

Showing 751 to 760 of 919 results

NHS ordered to provide guidance on Lyrica use


The English High Court has ordered the country’s National Health Service to issue guidance to medical professionals so that they prescribe Pfizer’s branded product Lyrica—not the generic version—for neuropathic pain.

Pharma companies ask Federal Circuit for validity ruling on Copaxone patent


Pharmaceutical companies Teva, Momenta, Mylan and Sandoz have asked the US Court of Appeals for the Federal Circuit for an expedited ruling on the validity of Teva’s patent covering its Copaxone drug.

US district court strikes down AstraZeneca’s Pulmicort patent


A US court has ruled that an AstraZeneca patent covering asthma inhaler Pulmicort Respules is invalid, allowing generic drug makers to enter the market with their own versions.

Novartis seeks injunction against proposed Zometa generic


Novartis has sued drug company BPI Labs for alleged patent infringement after it requested permission to market a generic version of Novartis’s bone cancer drug Zometa.

Gilead faces Sovaldi patent challenge in Europe


A medical aid non-profit organisation has opposed a European patent held by pharmaceutical company Gilead that covers its anti-hepatitis C drug Sovaldi.

Bayer itching to protect flea control range in patent suit


Bayer’s animal health division has filed for a declaratory judgment that SHP Chemical has infringed three patents covering a range of products that control fleas affecting cats and dogs.

NGO joins fight against Indian Sovaldi patent


Another party has thrown its hat into the ring in the fight to stop the issue of an Indian patent covering Sovaldi, a hepatitis C drug.

Teva gets green light for Nexium generic


The US Food and Drug Administration has approved an application by pharmaceutical company Teva to market a generic version of AstraZeneca’s heartburn drug Nexium.

English High Court swats Warner patent case against Actavis

UK22-01-2015Legal developments

The English High Court has said it will not send a patent infringement case filed by Pfizer-owned Warner-Lambert Company against Actavis to trial, finding there was no “serious issue”.

Teva in pre-emptive strike to protect proposed Byetta generic


Teva has filed for a declaratory judgment that it did not infringe patents belonging to AstraZeneca and Amylin Pharmaceuticals that protect diabetes drug Byetta (exenatide).

Showing 751 to 760 of 919 results